MDL | - |
---|---|
Molecular Weight | 499.52 |
Molecular Formula | C24H32F3N3O5 |
SMILES | CC(C)[C@@H](C(N1[C@H](C(N[C@H](C(C(F)(F)F)=O)C(C)C)=O)CCC1)=O)NC(C2=CC=C(OC)C=C2)=O |
Ki: 6.7 nM (Human neutrophil elastase), 200 nM (Human neutrophil elastase) [1]
ZD0892 administration to DBA/2 mice infected with the EMC virus results in reduced myocardial elastolytic activity and coronary microvascular perfusion injury. ZD0892 decreases the pathologic severity of the myocardial lesions associated with murine viral myocarditis [1] . ZD-0892 can reverse advanced pulmonary vascular disease produced in rats [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 250 mg/mL ( 500.48 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.0019 mL | 10.0096 mL | 20.0192 mL |
5 mM | 0.4004 mL | 2.0019 mL | 4.0038 mL |
10 mM | 0.2002 mL | 1.0010 mL | 2.0019 mL |